Dr Crispin Hiley is Clinical Director for lung cancer at GenesisCare UK, as well as Associate Professor with tenure in Oncology at UCL and a Consultant Clinical Oncologist at UCLH.

Dr Hiley specialises in non-surgical treatments for all types of lung cancer with expertise in chemotherapy, immunotherapy and state-of-the art radiotherapy techniques such as MRI guided adaptive radiotherapy and proton beam therapy. He specialises in the use of stereotactic radiotherapy (SBRT) for oligo metastatic and oligo progressive disease for many types of cancer including but not limited to lung, breast, prostate, colorectal, gynaecological and sarcoma.

He also specialises in the use of reirradiation (repeat radiotherapy) for patients who have received prior radiotherapy.

Considered one of the best oncologists in the UK, Dr Hiley has published in many of the world’s premier journals including Nature and the NEJM. He is the chief investigator of multiple clinical trials and has contributed to the Royal College of Radiologists Consensus Statement on Radiotherapy for Lung Cancer, setting the standard of practice in the UK.